Latest Coronavirus Disease COVID 19 News and Research
Study looks at how loneliness, perceived support has changed in response to COVID-19
Social distancing during the COVID-19 pandemic has not led to an overall increase in loneliness among Americans.
Easy to say ‘get tested.’ Harder to do. Here’s how.
Will Bondurant decided to get tested for COVID-19 after attending three racial justice demonstrations over a five-day period in San Francisco, where he lives.
Researchers explore notions of animality, illness and humanity
When it became apparent in early 2020 just how serious the COVID-19-pandemic was, prioritization among corona patients became an acute issue.
As problems grow with Abbott’s fast COVID test, FDA standards are under fire
In mid-May, the Food and Drug Administration issued a rare public warning about an Abbott Laboratories COVID-19 test that for weeks had received high praise from the White House because of its speed: Test results could be wrong.
How those with obsessive-compulsive disorder cope with added angst of COVID
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Researchers produce first fully-glycosylated full-length SARS-CoV-2 spike protein models
The virus SARS coronavirus 2 (SARS-CoV-2) is the known cause of coronavirus disease 2019 (COVID-19). The "spike" or S protein facilitates viral entry into host cells.
How to stay safe in summer as states ease coronavirus restrictions
As states lift some restrictions designed to protect public health against furthering the spread of COVID-19, people across the country are wondering how to safely engage in activities this summer such as gathering with friends, traveling and going to the beach.
Synthetic peptide could be an effective COVID-19 treatment and SARS-CoV-2 vaccine
Ligandal, one of the world’s leading genetic medicine companies, has modeled a synthetic peptide that could be an effective COVID-19 treatment and SARS-CoV-2 vaccine.
How weather affects COVID-19 in India
With India now having endured six months of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there are now over 410,000 official cases in and more than 13,000 deaths recorded. Almost all these deaths have occurred in the last three months, April to June, with 100 deaths on April 4, 2020, increasing almost 16-fold by May 4, and 63-fold by June 4, 2020.
SARS-CoV-2 saliva testing that omits the RNA extraction step
Even as the COVID-19 pandemic progresses throughout the world, the lack of consistent diagnostic testing has been a bugbear, preventing public health control of the spread of infection. A new study by researchers at the University of Illinois Urbana-Champaign and published on the preprint server bioRxiv in June 2020 reports a new testing method that uses saliva, does not require RNA extraction, and can be scaled up quickly and inexpensively.
Massive proteomics investigation of COVID-19 infection
Researchers from Germany and Switzerland revealed functional effects of individual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins on cellular level after infection. They placed the findings into the context of host signaling pathways in order to identify vulnerable parts of the virus amenable to treatment. The study is currently available on the bioRxiv preprint server.
A highly sensitive and specific antibody test for COVID-19
A new proof-of-concept study by UK researchers, currently available on the medRxiv* preprint server, describes the development of an enzyme-linked immunosorbent assay that can be used when lower levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific-antibodies are present in serum and saliva samples.
Research explores the biophysical behavior of SARS-CoV-2 nucleocapsid protein
In a groundbreaking paper currently available on the bioRxiv* preprint server, the researchers from the Washington University School of Medicine and Stony Brook University showed how nucleocapsid protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is dynamic, disordered and phase separates with RNA – informing, in turn, the discovery of drugs that disrupt viral packaging.
Interesting study on which species may be infected by SARS-CoV-2
The team from the University of Cambridge and the Pirbright Institute found that the Spike protein on SARS-CoV-2 engages with the host cell receptor angiotensin-converting enzyme 2 (ACE2) across a wide range of animals, even though the Spike binding site shows a between-species variation in its amino acid composition.
Promising candidate monoclonal antibodies show "exquisite potency" against SAR-CoV-2
Researchers at Columbia University, Dana-Farber Cancer Institute, and the National Institutes of Health have identified and characterized a range of monoclonal antibodies that potently neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Environmental conditions affect the stability of SARS-CoV-2, study finds
A new study led by Marshall University researcher M. Jeremiah Matson found that environmental conditions affect the stability of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human nasal mucus and sputum.
Systems approach needed to address challenges of globally interconnected food system
Global food production is incredibly efficient, and the world's farmers produce enough to feed the global population.
Drama-based resources help Kingston University nursing students to cope with coronavirus pandemic
A set of drama-based resources to help Kingston University, London nursing students working during the Covid-19 pandemic have been put together through a collaboration with world-leading performing arts school Guildhall School of Music & Drama, London.
Direct structural link between SARS-CoV-2 and essential fatty acid
Now, a new study published on the preprint server bioRxiv in June 2020 reports the discovery of a novel free fatty acid (FFA) binding pocket on the SARS-CoV-2 virus that could explain in part the viral effects of hyperinflammation, immune modulation, and membrane structure.
Balanced B and T cell response required to control SARS-CoV-2
A new study by researchers in the Netherlands and published on the preprint server bioRxiv in June 2020 describes the differences in T and B cell responses seen in patients with severe COVID-19.
.png)
No hay comentarios:
Publicar un comentario